PN Poong Nyun Co., Ltd. (KOSDAQ:024940)
1,936.00
+1.00 (0.05%)
At close: Sep 3, 2026
PN Poong Nyun Revenue
PN Poong Nyun had revenue of 12.50B KRW in the quarter ending June 30, 2026, a decrease of -2.33%. This brings the company's revenue in the last twelve months to 54.93B, down -3.01% year-over-year. In the year 2025, PN Poong Nyun had annual revenue of 56.04B with 1.99% growth.
Revenue (ttm)
54.93B
Revenue Growth
-3.01%
P/S Ratio
0.33
Revenue / Employee
378.80M
Employees
145
Market Cap
18.19B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 56.04B | 1.09B | 1.99% |
| Dec 31, 2024 | 54.95B | -2.28B | -3.99% |
| Dec 31, 2023 | 57.23B | -408.49M | -0.71% |
| Dec 31, 2022 | 57.64B | -771.05M | -1.32% |
| Dec 31, 2021 | 58.41B | 716.68M | 1.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SJ Group | 156.07B |
| Spolytech | 71.09B |
| ChoA Pharmaceutical Co., LTD. | 61.16B |
| SANGBO | 46.85B |
| DMOA Co., Ltd | 27.59B |
| Duoback | 24.73B |
| Catis. | 23.18B |
| Satoshi Holdings | 20.80B |